相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report
P. Malfertheiner et al.
GUT (2017)
Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues
David Y. Graham
GUT (2017)
Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection with Helicobacter pylori in Japan
Mitsushige Sugimoto et al.
HELICOBACTER (2017)
Increasing metronidazole and rifampicin resistance of Helicobacter pylori isolates obtained from children and adolescents between 2002 and 2015 in southwest Germany
Thomas Regnath et al.
HELICOBACTER (2017)
The internalization of Helicobacter pylori plays a role in the failure of H-pylori eradication
You-hua Wang et al.
HELICOBACTER (2017)
Recurrence of Helicobacter pylori infection and the affecting factors: A follow-up study
Li Ya Zhou et al.
JOURNAL OF DIGESTIVE DISEASES (2017)
Review article: the prevalence of Helicobacter pylori and the incidence of gastric cancer across Europe
S. E. Roberts et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Review article: the global emergence of Helicobacter pylori antibiotic resistance
I. Thung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication
Kai-feng Pan et al.
GUT (2016)
Prevalence of Primary Antimicrobial Resistance of H-pylori in Turkey: A Systematic Review
Bekir Kocazeybek et al.
HELICOBACTER (2016)
Emerging Role of Probiotics in the Management of Helicobacter Pylori Infection: Histopathologic Perspectives
Mohamed H. Emara et al.
HELICOBACTER (2016)
First-line Bismuth-containing Five-day Concomitant Quintuple Therapy for Helicobacter Pylori Eradication
Can Dolapcioglu et al.
HELICOBACTER (2016)
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial
Bumjo Oh et al.
HELICOBACTER (2016)
Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial
Liya Zhou et al.
HELICOBACTER (2016)
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA
Jason Y. Park et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Helicobacter pylori therapy: a paradigm shift
David Y. Graham et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2016)
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
Carlo A. Fallone et al.
GASTROENTEROLOGY (2016)
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study
Kazunari Murakami et al.
GUT (2016)
Role of bismuth in improving Helicobacter pylori eradication with triple therapy
Maria Pina Dore et al.
GUT (2016)
The Changing Profile of Helicobacter pylori Antibiotic Resistance in Singapore: A 15-Year Study
Tiing Leong Ang et al.
HELICOBACTER (2016)
Hybrid Therapy as First-Line Regimen for Helicobacter pylori Eradication in Populations with High Antibiotic Resistance Rates
Zhiqiang Song et al.
HELICOBACTER (2016)
Primary resistance of Helicobacter pylori is still low in Southern Austria
Ines Zollner-Schwetz et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial
Junbo Hong et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
Jyh-Ming Liou et al.
LANCET (2016)
The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China
Zizhong Ji et al.
MEDICINE (2016)
Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis
Han Chen et al.
MEDICINE (2016)
High-Level Primary Clarithromycin Resistance of Helicobacter pylori in Algiers, Algeria: A Prospective Multicenter Molecular Study
Fazia Djennane-Hadibi et al.
MICROBIAL DRUG RESISTANCE (2016)
Multicenter Study of Antibiotic Resistance Profile of H-pylori and Distribution of CYP2C19 Gene Polymorphism in Rural Population of Chongqing, China
Ran Han et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea
WonGun Kwack et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
The Prevalence of Helicobacter pylori Infection in Symptomatic Children: A 13-Year Observational Study in the Lower Silesian Region
Monika M. Biernat et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2016)
Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA
Peter Nagy et al.
GUT PATHOGENS (2016)
Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events
Lynne V. McFarland et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2016)
EVALUATION OF ANTIMICROBIAL RESISTANCE OF HELICOBACTER PYLORI IN THE LAST 15 YEARS IN WEST POLAND
Tomasz M. Karpinski et al.
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA (2015)
High Helicobacter pylori cure rate with sitafloxacin-based triple therapy
M. Sugimoto et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection
H. Szajewska et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Prevalence and risk factors of Helicobacter pylori infection in asymptomatic Chinese children: a prospective, cross-sectional, population-based study
Z. Ding et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection
Jyh-Chin Yang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans
Seiji Shiota et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection
Qian Liu et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy
Wei Zhang et al.
GUT (2015)
Kyoto global consensus report on Helicobacter pylori gastritis
Kentaro Sugano et al.
GUT (2015)
Editorial - Avoiding Unethical Helicobacter pylori Clinical Trials: Susceptibility-Based Studies and Probiotics as Adjuvants
David Y. Graham
HELICOBACTER (2015)
The Prevalence of Helicobacter pylori Remains High in African American and Hispanic Veterans
Theresa Nguyen et al.
HELICOBACTER (2015)
High-level primary clarithromycin resistance of Helicobacter pylori in Morocco: a prospective multicenter molecular study
Najat Bouilhat et al.
HELICOBACTER (2015)
Time Trends in Helicobacter pylori Infection and Atrophic Gastritis Over 40Years in Japan
Tomoari Kamada et al.
HELICOBACTER (2015)
Molecular Detection of Helicobacter pylori and its Antimicrobial Resistance in Brazzaville, Congo
Esther Nina Ontsira Ngoyi et al.
HELICOBACTER (2015)
Susceptibility of Helicobacter pylori to antibiotics in Chinese patients
Peng Bai et al.
JOURNAL OF DIGESTIVE DISEASES (2015)
Probiotics in Helicobacter pylori eradication therapy: A systematic review and meta-analysis
Min-Min Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Seven-day quintuple regimen as a rescue therapy for Helicobacter pylori eradication
Fariborz Mansour-Ghanaei et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study
Yue-Xi Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Roadmap for elimination of gastric cancer in Korea
David Y. Graham
KOREAN JOURNAL OF INTERNAL MEDICINE (2015)
Reinfection after successful eradication of Helicobacter pylori in three different populations in Alaska
M. G. Bruce et al.
EPIDEMIOLOGY AND INFECTION (2015)
Low Antibiotic Resistance of Helicobacter pylori in The Netherlands
Petronella E. C. Mourad-Baars et al.
HELICOBACTER (2015)
Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication A Multicenter, Prospective, Randomized Controlled Study in Japan
Toshihiro Nishizawa et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
Helicobacter pylori Infection in Thailand: A Nationwide Study of the CagA Phenotype
Tomohisa Uchida et al.
PLOS ONE (2015)
Changing Prevalence of Helicobacter pylori Infections in Korean Children with Recurrent Abdominal Pain
Kyung Mi Jang et al.
PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION (2015)
A Comparative Study of Sequential Therapy and Standard Triple Therapy for Helicobacter pylori Infection: A Randomized Multicenter Trial
Liya Zhou et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
The Problem of Helicobacter pylori Resistance to Antibiotics: A Systematic Review in Latin America
M. Constanza Camargo et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
David Y. Graham et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
The Evolution of Helicobacter Pylori Antibiotics Resistance Over 10 Years in Greece
Georgios P. Karamanolis et al.
DIGESTION (2014)
Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients
Zhiqiang Song et al.
DIGESTIVE AND LIVER DISEASE (2014)
Antimicrobial Resistance and Characteristics of Eradication Therapy of Helicobacter pylori in Japan: A Multi-Generational Comparison
Takuma Okamura et al.
HELICOBACTER (2014)
High-Dose Extended-Release Lansoprazole (Dexlansoprazole) and Amoxicillin Dual Therapy for Helicobacter pylori Infections
Taraq A. Attumi et al.
HELICOBACTER (2014)
Helicobacter pylori Recurrence after First- and Second-Line Eradication Therapy in Korea: The Problem of Recrudescence or Reinfection
Seung Young Kim et al.
HELICOBACTER (2014)
Recurrence of Helicobacter pylori Infection in Bolivian Children and Adults After a Population-Based Screen and Treat Strategy
Sumathi Sivapalasingam et al.
HELICOBACTER (2014)
Prevalence of Helicobacter pylori infection with healthy subjects in Japan
Yoji Hirayama et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Evolution of Amoxicillin Resistance of Helicobacter pylori In Vitro: Characterization of Resistance Mechanisms
Nadia N. Qureshi et al.
MICROBIAL DRUG RESISTANCE (2014)
The Effect of Probiotics Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis
Yini Dang et al.
PLOS ONE (2014)
Standard triple therapy for Helicobacter pylori infection in China: A meta-analysis
Ben Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection
Yong Xie et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
CYP2C19 polymorphism influences Helicobacter pylori eradication
Chao-Hung Kuo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials
Alexander C. Ford et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
National rates of Helicobacter pylori recurrence are significantly and inversely correlated with human development index
T. -L. Yan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole
S. Sahara et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy
Min Soo Kim et al.
BMC GASTROENTEROLOGY (2013)
Prevalence and risk factors of Helicobacter pylori infection in Korea: Nationwide multicenter study over 13 years
Seon Hee Lim et al.
BMC GASTROENTEROLOGY (2013)
Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)
Carolina Porras et al.
CANCER CAUSES & CONTROL (2013)
Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study
Xiao Liang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention
Yi-Chia Lee et al.
GUT (2013)
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption
Francis Megraud et al.
GUT (2013)
Long-term Follow-up Helicobacter Pylori Reinfection Rate and Its Associated Factors in Korea
Min Soo Kim et al.
HELICOBACTER (2013)
Prevalence of Primary and Secondary Antimicrobial Resistance of Helicobacter pylori in Korea from 2003 through 2012
Jung Won Lee et al.
HELICOBACTER (2013)
Antibiotic Resistance of Helicobacter Pylori Isolated in the Southeast Coastal Region of China
Peng Su et al.
HELICOBACTER (2013)
Effect of Fluoroquinolone Resistance on 14-day Levofloxacin Triple and Triple Plus Bismuth Quadruple Therapy
Jingxian Liao et al.
HELICOBACTER (2013)
Meta-Analysis of the Efficacy and Safety of Lactobacillus-containing and Bifidobacterium-containing Probiotic Compound Preparation in Helicobacter pylori Eradication Therapy
Zhen-Hua Wang et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection
Wen Zhong Liu et al.
JOURNAL OF DIGESTIVE DISEASES (2013)
Comparative Proteomics Analysis of Sarcoshie Insoluble Outer Membrane Proteins from Clarithromycin Resistant and Sensitive Strains of Helicobacter pylori
Rebecca Smiley et al.
JOURNAL OF MICROBIOLOGY (2013)
Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco)
Dafr Allah Benajah et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2013)
Antibiotic Resistance in Helicobacter pylori Strains and its Effect on H-pylori Eradication Rates in a Single Center in Korea
Byoungrak An et al.
ANNALS OF LABORATORY MEDICINE (2013)
Effect of Helicobacter pylori eradication on glycaemia control in patients with type 2 diabetes mellitus and comparison of two therapeutic regimens
Jamshid Vafaeimanesh et al.
ARAB JOURNAL OF GASTROENTEROLOGY (2013)
High-dose rabeprazole-amoxicillin dual therapy and rabeprazole triple therapy with amoxicillin and levofloxacin for 2 weeks as first and second line rescue therapies for Helicobacter pylori treatment failures
K-L Goh et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Fluoroquinolone Resistance in Helicobacter pylori: Role of Mutations at Position 87 and 91 of GyrA on the Level of Resistance and Identification of a Resistance Conferring Mutation in GyrB
Emiko Rimbara et al.
HELICOBACTER (2012)
Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan
Susumu Take et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Age of the Association between Helicobacter pylori and Man
Yoshan Moodley et al.
PLOS PATHOGENS (2012)
Gastric Atrophy and Intestinal Metaplasia before and after Helicobacter pylori Eradication: A Meta-Analysis
Jin Wang et al.
DIGESTION (2011)
Epidemiology of Helicobacter pylori Infection and Public Health Implications
Khean-Lee Goh et al.
HELICOBACTER (2011)
Resistance of Helicobacter pylori to quinolones and clarithromycin assessed by genetic testing in Japan
Mihoko Yamade et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
A Study Comparing the Antisecretory Effect of TAK-438, a Novel Potassium-Competitive Acid Blocker, with Lansoprazole in Animals
Yasunobu Hori et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
Peter Malfertheiner et al.
LANCET (2011)
Assessing the role of the RND efflux pump in metronidazole resistance of Helicobacter pylori by RT-PCR assay
Jalil Fallah Mehrabadi et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2011)
Characterization of a Novel Potassium-Competitive Acid Blocker of the Gastric H,K-ATPase, 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438)
Jai Moo Shin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment
H. Szajewska et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk
Lydia E. Wroblewski et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Helicobacter pylori treatment in the era of increasing antibiotic resistance
David Y. Graham et al.
GUT (2010)
A Randomized Controlled Trial: Efficacy and Safety of Azithromycin, Ofloxacin, Bismuth, and Omeprazole Compared With Amoxicillin, Clarithromycin, Bismuth, and Omeprazole as Second-Line Therapy in Patients With Helicobacter pylori Infection
Mohammad Minakari et al.
HELICOBACTER (2010)
Helicobacter pylori Reinfection in Brazilian Patients with Peptic Ulcer Disease: A 5-Year Follow-Up
Fernando M. Silva et al.
HELICOBACTER (2010)
High Efficacy of 14-Day Triple Therapy-Based, Bismuth-Containing Quadruple Therapy for Initial Helicobacter pylori Eradication
Qinjuan Sun et al.
HELICOBACTER (2010)
Seroprevalence and Potential Risk Factors for Helicobacter pylori Infection in Brazilian Children
Vitor Camilo Cavalcante Dattoli et al.
HELICOBACTER (2010)
The Evolution of Helicobacter pylori Antibiotics Resistance Over 10 Years in Beijing, China
Wen Gao et al.
HELICOBACTER (2010)
Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance
Qing Zheng et al.
JOURNAL OF DIGESTIVE DISEASES (2010)
Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States
David Y. Graham et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori
Kenro Hirata et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases
Yasunobu Hori et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Helicobacter pylori Infection
Kenneth E. L. McColl
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome
Hedvig E. Jakobsson et al.
PLOS ONE (2010)
Influence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori
Zhan Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Amoxicillin resistance with beta-lactamase production in Helicobacter pylori
Y. -S. Tseng et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Meta-Analysis: Lactobacillus Containing Quadruple Therapy Versus Standard Triple First-Line Therapy for Helicobacter pylori Eradication
Jian Zou et al.
HELICOBACTER (2009)
Annual Change of Primary Resistance to Clarithromycin among Helicobacter pylori Isolates from 1996 through 2008 in Japan
Noriyuki Horiki et al.
HELICOBACTER (2009)
Urea Breath Test in Children: The United States Prospective, Multicenter Study
Yoram Elitsur et al.
HELICOBACTER (2009)
Genetic analysis of Helicobacter pylori clinical isolates suggests resistance to metronidazole can occur without the loss of functional rdxA
So Yeong Kim et al.
JOURNAL OF ANTIBIOTICS (2009)
Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori
Mona Anoushiravani et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori
Emiko Rimbara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori
Emiko Rimbara et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Changes in the presence of urine Helicobacter pylori antibody in Japanese children in three different age groups
Yukiko Naito et al.
PEDIATRICS INTERNATIONAL (2008)
Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis
Alexander C. Ford et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005
Intetsu Kobayashi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
A quintuple therapy for H-Pylori eradication
Angelo Zullo et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Differentially expressed genes in response to amoxicillin in Helicobacter pylori analyzed by RNA arbitrarily primed PCR
Anita P. O. Godoy et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2007)
Helicobacter pylori eradication:: A randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics
Nicola de Bortoli et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Update on fluoroquinolone resistance in Helicobacter pylori:: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility
Vincent Cattoir et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Meta-analysis:: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy
J. L. Tong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
The effect of CYP2C19 polymorphisms on H-Pylori eradication rate in dual and triple first-line PPI therapies:: A meta-analysis
Sara Padol et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
High rate of Helicobacter pylori reinfection in children and adolescents
F Halitim et al.
HELICOBACTER (2006)
The recurrence of Helicobacter pylori infection: Incidence and variables influencing it. A critical review
JP Gisbert
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
H pylori antibiotic resistance:: prevalence, importance, and advances in testing
F Mégraud
GUT (2004)
Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection
GK Anagnostopoulos et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment:: randomized, double-blind, placebo controlled trial
EC Nista et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States
WM Duck et al.
EMERGING INFECTIOUS DISEASES (2004)
Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori
MM Gerrits et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori
J Tankovic et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori
T Okamoto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Reinfection rate in children after successful Helicobacter pylori eradication
A Feydt-Schmidt et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori
MM Gerrits et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Risk factors for Helicobacter pylori resistance in the United States: The surveillance of H-pylori antimicrobial resistance partnership (SHARP) study, 1993-1999
JM Meyer et al.
ANNALS OF INTERNAL MEDICINE (2002)
European Multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori
Y Glupczynski et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2001)
Current role of acid suppressants in Helicobacter pylori eradication therapy
J Labenz
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2001)
Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan
M Kato et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis
M Heep et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
